Results 221 to 230 of about 106,316 (267)
Some of the next articles are maybe not open access.
Biobanks and biobank harmonisation
2017Over the past decade and a half, genetic epidemiology has experienced an important shift from family-based studies of genetic linkage to individual-based studies of genetic association (Chapters One-Four). In part, this follows the recognition that if the 'common disease, common variant hypothesis'1-5 is true for at least a proportion of important ...
Burton, P. +4 more
openaire +1 more source
Biobanking and Pharmacogenomics
Pharmacogenomics, 2010The study of genetic determinants underlying drug outcome is rapidly advancing. Initial success was realized within the context of candidate pharmacokinetic genes and serious adverse drug reactions, particularly for drugs with narrow therapeutic indices.
Catherine A, McCarty, Russell A, Wilke
openaire +2 more sources
Public Health, 2012
Biobanks are a key resource in unravelling the association between genetic background, lifestyle and environmental determinants of the incidence, natural course and treatment response for various complex diseases and health traits. Biobanks are goldmines for epidemiological research, provided that they are set up properly, enable multicentre ...
openaire +2 more sources
Biobanks are a key resource in unravelling the association between genetic background, lifestyle and environmental determinants of the incidence, natural course and treatment response for various complex diseases and health traits. Biobanks are goldmines for epidemiological research, provided that they are set up properly, enable multicentre ...
openaire +2 more sources
Biopreservation and Biobanking, 2014
Tight economic realities in clinical and research operations have spurred the need to re-examine financial models that support the infrastructure of biobanking. Finding ways to streamline operations, trim costs, and become more conscious of the carbon footprint of biobank operations has made ‘‘sustainability’’ a well-used buzzword of our time.
Daniel, Simeon-Dubach +1 more
openaire +2 more sources
Tight economic realities in clinical and research operations have spurred the need to re-examine financial models that support the infrastructure of biobanking. Finding ways to streamline operations, trim costs, and become more conscious of the carbon footprint of biobank operations has made ‘‘sustainability’’ a well-used buzzword of our time.
Daniel, Simeon-Dubach +1 more
openaire +2 more sources
2015
Nurses are a pivotal component of the translational research movement and apply scientific discoveries to the healthcare and clinical practice fields. Biobanking is also an important factor in furthering translational research by providing biospecimens and related clinical data to the research community.
Jennifer, Sanner +2 more
openaire +2 more sources
Nurses are a pivotal component of the translational research movement and apply scientific discoveries to the healthcare and clinical practice fields. Biobanking is also an important factor in furthering translational research by providing biospecimens and related clinical data to the research community.
Jennifer, Sanner +2 more
openaire +2 more sources
Journal of Law, Medicine & Ethics, 2016
Estonia is a democratic, parliamentary republic with a health care system that is built on the principle of compulsory, solidarity-based insurance and the all-round availability of services of private service providers. Estonia has specific biobank legislation as well as oversight via data protection laws.
openaire +2 more sources
Estonia is a democratic, parliamentary republic with a health care system that is built on the principle of compulsory, solidarity-based insurance and the all-round availability of services of private service providers. Estonia has specific biobank legislation as well as oversight via data protection laws.
openaire +2 more sources
Biobank Continuity Management: A Survey of Biobank Professionals
Biopreservation and Biobanking, 2019Academic biobanks face challenges that call for continuity and disaster planning. However, current regulations do not require such planning, so it is unclear if and how biobanks have prepared themselves to deal with future crises. This exploratory study used mixed methods to understand the state of continuity planning in U.S. biobanks.
Terry David, Church, Frances J, Richmond
openaire +2 more sources
Cambridge Quarterly of Healthcare Ethics, 2004
Due to modern biochemistry and, in particular, recent developments in genomics, proteomics, and bioinformatics, human samples (organs, tissues, cells, genes, etc.) have become the most important raw materials for advancement in the health sciences. Such material has been at the center of fundamental biomedical research for a long time. What is new
openaire +2 more sources
Due to modern biochemistry and, in particular, recent developments in genomics, proteomics, and bioinformatics, human samples (organs, tissues, cells, genes, etc.) have become the most important raw materials for advancement in the health sciences. Such material has been at the center of fundamental biomedical research for a long time. What is new
openaire +2 more sources
2015
Biobanks are playing increasingly important roles in clinical and translational research nowadays. China, as a country with the largest population and abundant clinical resources, attaches great importance to the development of biobanks. In recent years, with the increasing support from the Chinese government, biobanks are blooming across the country ...
Yong, Zhang +3 more
openaire +2 more sources
Biobanks are playing increasingly important roles in clinical and translational research nowadays. China, as a country with the largest population and abundant clinical resources, attaches great importance to the development of biobanks. In recent years, with the increasing support from the Chinese government, biobanks are blooming across the country ...
Yong, Zhang +3 more
openaire +2 more sources
Transplantation Proceedings, 2012
Possible adverse events and reactions associated with organ procurement and transplantation from deceased donors require compliance with quality and safety standards. Shortage of organs for transplantation makes it necessary to obtain organs from nonstandard (expanded-criteria) donors.
openaire +2 more sources
Possible adverse events and reactions associated with organ procurement and transplantation from deceased donors require compliance with quality and safety standards. Shortage of organs for transplantation makes it necessary to obtain organs from nonstandard (expanded-criteria) donors.
openaire +2 more sources

